AstraZeneca - Global Clinical Late Development, Oncology
Rutgers, the State University of New Jersey
Application
Details
Posted: 10-Oct-24
Location: Gaithersburg, Maryland
Type: Fellowship
Job Setting:
Pharmaceutical Science/Industry
Specialty Practice Areas:
Oncology
Required Education:
PharmD
1 position(s) for Global Clinical Late Development, Oncology
Fellowship Position Office Location: Gaithersburg, MD 20878
POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and AstraZeneca. Program emphasis is in Global Clinical Late Development, Oncology.
This 2-year Fellowship provides a unique opportunityto become a high-performing Medical/Clinical Scientist with experience in all stages of a clinical development program, including the planning, execution and readout of oncology clinical studies.
The Fellow will serve as a member of the Clinical Development team, working in close collaboration with the Global Study Team in a matrix environment to support the planning and execution, including trial design, study set up, recruitment and delivery, as well as data interpretation of a clinical study. The fellow will Provide clinical support for the late phase AstraZeneca-sponsored clinical program strategies, providing clinical input into the design & implementation of clinical trial(s), their delivery, clinical data review and monitoring, interpretation of results, reporting successfully on time, and activities required for worldwide registration of the product. The fellowship will ensure foundational clinical science capabilities are developed, while providing the opportunity to expand expertise with projects in additional areas of interest.
University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
The RPIF Program application portal opens at 9 AM ET on October 11th. Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 21st. To apply, candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu/how-to-apply/) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below.Remember that the application process is on a rolling basis, so earlier is better. Please see our website for additional important recruitment information and dates.
Initial offers will not be made until December 16th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status.
Candidate Checklist:
Create an RPIF Candidate Account starting now.
Upload RPIF Application Materials to RPIF Candidate Account starting October 11, 2024.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 18, 2024.
Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2024.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.
Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.